Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy

PURPOSE: To report the development of type 3 macular neovascularization (MNV) in a patient with pentosan polysulfate sodium (PPS) maculopathy one year after PPS cessation. OBSERVATION: A 72-year-old woman presented for decreased visual acuity in the left eye. Medical history was significant for inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousquet, Elodie, Lee, Brian A., Santina, Ahmad, Sadda, SriniVas, Sarraf, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763375/
https://www.ncbi.nlm.nih.gov/pubmed/36561881
http://dx.doi.org/10.1016/j.ajoc.2022.101771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763375/
https://www.ncbi.nlm.nih.gov/pubmed/36561881
http://dx.doi.org/10.1016/j.ajoc.2022.101771

Ejemplares similares